Atlas Trials

Plus Therapeutics

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Plus Therapeutics

RecordFirmDate
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma (NCT07061626)Plus Therapeutics2025-09-01
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (NCT07098806)Plus Therapeutics2025-07-02
Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment (NCT05460507)Plus Therapeutics2024-12-12
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (NCT05034497)Plus Therapeutics2021-12-06
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) (NCT01906385)Plus Therapeutics2015-06-03

Track Plus Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.